Cross-study comparisons suggest that systemic exposure ( AUC ) to rosuvastatin calcium , a 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitor , may be approximately 2-fold higher in Asian subjects living in Asian countries than in white subjects living in Western countries .
